Fr. 146.00

Follicular Lymphoma, An Issue of Hematology/Oncology Clinics of North America

English · Hardback

Shipping usually within 3 to 5 weeks

Description

Read more

This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Jonathan W. Friedberg, is devoted to Follicular Lymphoma. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Articles in this important issue include: Epidemiology of Follicular Lymphoma, Pathogenesis of Follicular Lymphoma, Circulating tumor DNA and MRD assessment in Follicular Lymphoma, Clinical and biological prognostic factors in Follicular Lymphoma, Vitamin D and Follicular Lymphoma, Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma, Initial Treatment of High Tumor Burden Follicular Lymphoma, Maintenance Antibody Therapy of Follicular Lymphoma, Cellular Therapy in Follicular Lymphoma, Immunomodulatory Agents in Follicular Lymphoma, Phosphoinositide 3-Kinase Inhibition in Follicular Lymphoma, Novel Agents Beyond Immunomodulatory Imide Drugs and Phosphoinositide 3-Kinases for Follicular Lymphoma, Early progression of Follicular Lymphoma, Biological Basis of Histological Transformation, and Treatment of Histological Transformation.

Product details

Assisted by Jonathan W Friedberg (Editor), Jonathan W Friedberg (Editor)
Publisher Elsevier Health Science
 
Languages English
Product format Hardback
Released 26.06.2020
 
EAN 9780323754385
ISBN 978-0-323-75438-5
Dimensions 152 mm x 228 mm x 229 mm
Weight 430 g
Series The Clinics: Internal Medicine
Subjects Natural sciences, medicine, IT, technology > Medicine > Clinical medicine

MEDICAL / Hematology, Haematology

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.